ABBV Summary

  1. NYSE
  2. >
  3. ABBV
TickerABBV
DescriptionABBVIE INC
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
ExchangeNYSE
TypeStock
SectorHealthcare
Employees30,000
Next Earnings DateOctober 30th, 2020
IV31.845798%
IV Percentile73rd
IV Rank24.76%
IV Skew14.819819
IV Skew Percentile73rd
IV Skew SentimentBearish
Option Volume20,383
Volume9,767,145
Price$83.26
Previous Close$84.25
52-Week High$101.28
52-Week Low$62.55
50-Day Moving Avg.$90.31
200-Day Moving Avg.$88.99
10-Day Avg. Volume6,724,934
20-Day Avg. Volume7,125,238
30-Day Avg. Volume7,011,824
3-Month Avg. Volume7,045,679
PE72.68103
EPS$1.16
Outstanding Shares1,764,830,000
Float1,762,599,255
Market Capitalization$148,793,091,000
CurrencyUSD
UpdatedOctober 21st, 2020